FDA licenses 15 new blood typing tests

The U.S. Food and Drug Administration has licensed 15 new blood typing tests that were previously unavailable in the United States.

These tests, known as blood grouping reagents, are used to determine the blood type of blood donors, an essential step in ensuring safe blood transfusion for patients. If mismatched blood is administered to a patient, it may cause a serious and potentially fatal reaction.

To prevent such problems, people must receive compatible blood based on the results of blood typing tests